EXAGEN INC. - Common (XGN)

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Common
Shares outstanding
22,804,407
Total 13F shares
6,285,386
Share change
+80,632
Total reported value
$11,440,080
Put/Call ratio
8%
Price per share
$1.82
Number of holders
32
Value change
+$146,598
Number of buys
11
Number of sells
12

Institutional Holders of EXAGEN INC. - Common (XGN) as of Q2 2024

As of 30 Jun 2024, EXAGEN INC. - Common (XGN) was held by 32 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,285,386 shares. The largest 10 holders included RTW INVESTMENTS, LP, COWEN AND COMPANY, LLC, WASATCH ADVISORS LP, SILVERCREST ASSET MANAGEMENT GROUP LLC, PERKINS CAPITAL MANAGEMENT INC, VANGUARD GROUP INC, MORGAN STANLEY, Stonepine Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 32 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.